China Ovarian Cancer BRCA Testing Study

TerminatedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

January 31, 2018

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Ovarian Cancer
Trial Locations (19)

0

Research Site, Hong Kong

100142

Research Site, Beijing

100191

Research Site, Beijing

100730

Research Site, Beijing

200032

Research Site, Shanghai

200080

Research Site, Shanghai

230601

Research Site, Hefei

250014

Research Site, Jinan

300110

Research Site, Tianjin

300202

Research Site, Tianjin

310006

Research Site, Hangzhou

400030

Research Site, Chongqing

410000

Research Site, Changsha

430030

Research Site, Wuhan

450008

Research Site, Zhengzhou

510060

Research Site, Guangzhou

510080

Research Site, Guangzhou

510220

Research Site, Guangzhou

610041

Research Site, Chengdu

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY